C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/04 (2006.01) A61K 35/76 (2006.01) A61K 39/00 (2006.01) A61K 39/245 (2006.01) C07K 14/035 (2006.01) C12N 7/01 (2006.01) C12N 15/85 (2006.01) C12N 15/86 (2006.01) C12N 15/869 (2006.01) A61K 38/00 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2193491
A method for killing malignant brain tumor cells in vivo entails providing replication competent herpes simplex virus vectors to tumor cells. A replication competent herpes simplex virus vector, with defective expression of the .gamma.34,5 gene and the ribonucleotide reductase gene, specifically destroys tumor cells, is hypersensitive to anti-viral agents, and yet is not neurovirulent.
Procédé permettant de tuer in vivo des cellules tumorales malignes du cerveau, consistant à mettre ces cellules en contact avec des vecteurs du virus de l'herpès simplex à compétition de réplication. Un vecteur du virus de l'herpès simplex à compétition de réplication, présentant une expression défectueuse du gène .gamma.34.5 et du gène de ribonucléotide réductase, détruit spécifiquement les cellules tumorales, et est hypersensible aux agents antiviraux sans être neurovirulent.
Martuza Robert L.
Mineta Toshihiro
Rabkin Samuel D.
Georgetown University
Smart & Biggar
LandOfFree
Replication-competent herpes simplex virus mediates... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Replication-competent herpes simplex virus mediates..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Replication-competent herpes simplex virus mediates... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1562775